Conditions: Recurrent Head and Neck Carcinoma; Locally Advanced Head and Neck Carcinoma
Interventions: Biological: Nivolumab; Drug: Porfimer Sodium; Procedure: Interstitial Illumination Photodynamic Therapy; Biological: Pembrolizumab; Drug: Cisplatin; Drug: Carboplatin; Biological: Cetuximab; Other: Quality of Life Assessment; Drug: Fluorouracil
Sponsors: Roswell Park Cancer Institute; National Cancer Institute (NCI)
Not yet recruiting
https://ift.tt/2P1FbXj
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου